Last reviewed · How we verify

NCT04835857

Comparison of Cuff-Less Wrist Wearable Blood Pressure Device to Cuff Based Blood Pressure Measuring Devices

Recruiting now Last updated 5 September 2025
What this trial tests

trial testing ViTrack in Hypertension in 91 participants. Currently enrolling.

Timeline
1 January 2021
Primary endpoint
1 June 2026
30 November 2026

Quick facts

Lead sponsorDynocardia, Inc
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment91
Start date1 January 2021
Primary completion1 June 2026
Estimated completion30 November 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Dynocardia, Inc

Who can join

Adults 18 to 90, any sex, with Hypertension or Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

(1) To compare cuff-less wrist wearable radial artery blood pressure measurements utilizing ViTrack(developed by Dynocardia) to the cuff based commercially available blood pressure device, in healthy volunteers with normal or high blood pressure.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of ViTrack

Trials testing the same drug.

Other recruiting trials for Hypertension

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04835857.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing